Literature DB >> 8682199

The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.

C Weissmann1.   

Abstract

The prion, the transmissible agent that causes spongiform encephalopathies such as scrapie, bovine spongiform encephalopathy (BSE) and Creutzfeldt-Jakob disease, is believed to be devoid of nucleic acid and identical with PrPSc, a modified form of the normal host protein PrPC which is encoded by the single copy gene Prnp. The 'protein only' hypothesis proposes that PrPSc, when introduced into a normal host, causes the conversion of PrPC into PrPSc; it therefore predicts that an animal devoid of PrPC should be resistant to prion diseases. We generated homozygous Prnp(olo) ('PrP knockout') mice and showed that, after inoculation with prions, they remained free of scrapie for at least 2 years while wild-type controls all died within 6 months. There was no propagation of prions in the Prnp(olo) animals. Surprisingly, heterozygous Prnp(ol+) mice, which express PrPC at about half the normal level, also showed enhanced resistance to scrapie disease despite high levels of infectious agent and PrPSc in the brain early on. After introduction of murine PrP transgenes Prnp(olo) mice became highly susceptible to mouse but not to hamster prions, while the insertion of Syrian hamster PrP transgenes rendered them susceptible to hamster but to a much lesser extent to mouse prions. These complementation experiments paved the way to the application of reverse genetics. We have prepared animals transgenic for genes encoding PrP with amino terminal deletions of various lengths and have found that PrP lacking 48 amino proximal amino acids, which comprise four of the five octa repeats of PrP, is still biologically active.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682199     DOI: 10.1016/0014-5793(96)00610-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

3.  Influence of the N-terminal domain on the aggregation properties of the prion protein.

Authors:  Kristen N Frankenfield; Evan T Powers; Jeffery W Kelly
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

4.  Prion protein NMR structure and species barrier for prion diseases.

Authors:  M Billeter; R Riek; G Wider; S Hornemann; R Glockshuber; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Molecular dynamics simulation of temperature induced unfolding of animal prion protein.

Authors:  Xin Chen; Danhui Duan; Shuyan Zhu; Jinglai Zhang
Journal:  J Mol Model       Date:  2013-08-08       Impact factor: 1.810

6.  Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing.

Authors:  G P Newnam; R D Wegrzyn; S L Lindquist; Y O Chernoff
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

7.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

8.  Sleep and sleep regulation in normal and prion protein-deficient mice.

Authors:  I Tobler; T Deboer; M Fischer
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

9.  The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog.

Authors:  V Coustou; C Deleu; S Saupe; J Begueret
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

10.  NMR solution structure of the human prion protein.

Authors:  R Zahn; A Liu; T Lührs; R Riek; C von Schroetter; F López García; M Billeter; L Calzolai; G Wider; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.